Pharmaceutical / Drug Definition :
Inhibits calcium transport into myocardial and vascular smooth muscle cells, causing cardiac output and myocardial contractions to decrease
FDA Label Requirements and Exceptions
Nicardipine Hydrochloride
FDA Import Information
Nicardipine Hydrochloride
FDA Detentions
Nicardipine Hydrochloride (Nicardipine Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Nicardipine Hydrochloride (Nicardipine Hydrochloride Suppliers)
- Processors Nicardipine Hydrochloride
- Repackers Nicardipine Hydrochloride
- Relabelers Nicardipine Hydrochloride
- Exporters Nicardipine Hydrochloride
- Importers Nicardipine Hydrochloride
For more information about Nicardipine Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
